A Comparative Study of Patient Satisfaction Between Continued Administration of Previous Antipsychotics Versus Switched Administration to Paliperidone ER in Non-satisfied Patients With Previous Antipsychotic Drug
NCT01592201 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 13
Last updated 2014-06-25
Summary
The purpose of this study is to compare the patient satisfaction between continued administration of previous antipsychotics versus switched administration to paliperidone ER in non-satisfied patients with previous (paliperidone)
Conditions
Interventions
- DRUG
-
Paliperdidone ER
Form = osmotic release oral system, route = oral
- DRUG
-
Aripiprazole, olanzapine and risperidone (Antipsychotics)
Form = tablet, route = oral
Sponsors & Collaborators
-
Janssen Korea, Ltd., Korea
lead INDUSTRY
Principal Investigators
-
Janssen Korea, Ltd., Korea Clinical Trial · Janssen Korea, Ltd., Korea
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-07-31
- Primary Completion
- 2013-06-30
- Completion
- 2013-06-30
Countries
- South Korea
Study Locations
More Related Trials
-
Paliperidone Extended-Release (ER) Versus Risperidone for Neurocognitive Function in Patients With Schizophrenia
NCT00827840 ·Status: COMPLETED ·Phase: PHASE4
-
Phase 4 Study to Evaluate Efficacy of Paliperidone Extended-Release(ER) in Schizophrenic Participants
NCT00761605 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Compare the Effectiveness and Safety of Flexibly Varied Doses of Paliperidone Palmitate and Risperidone in Treating Patients With Schizophrenia
NCT00210717 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Paliperidone Palmitate and RISPERDAL CONSTA in Patients With Schizophrenia
NCT00589914 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of Paliperidone to Evaluate Subjective Change in Well-being and Drug Attitude in Schizophrenic Participants
NCT00784238 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics
NCT01685931 ·Status: COMPLETED ·Phase: PHASE4
-
Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital
NCT01193166 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Study of Extended Release Extended-release (ER) OROS Paliperidone Tolerability, as Compared to Immediate-release (IR)Risperidone, in Patients With Schizophrenia
NCT00791232 ·Status: COMPLETED ·Phase: PHASE1
-
Different Safety Profile of Risperidone and Paliperidone Extended-release
NCT01284959 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-up
NCT02532491 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study of Flexibly Dosed Paliperidone Extended Release Tablets in Participants With Schizophrenia
NCT01541371 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Transition to the Paliperidone Palmitate 3-Month Formulation In Participants With Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month Formulation
NCT02713282 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing the Safety and Efficacy of Ziprasidone and Risperidone for the Treatment of Chronic Schizophrenia
NCT00645515 ·Status: TERMINATED ·Phase: PHASE3
-
A Study to Evaluate the Effectiveness and Safety of Paliperidone Palmitate in Subjects With Acute Schizophrenia
NCT01527305 ·Status: COMPLETED ·Phase: PHASE4
-
An Efficacy, Safety And Tolerability Study of Flexibly Dosed Paliperidone Extended-Release (ER) in Participants With Schizophrenia
NCT00757705 ·Status: COMPLETED ·Phase: PHASE4
-
PaliperidoNe Extended-Release [ER] Dosing and Clinical Response in Acute Schizophrenia
NCT00761189 ·Status: COMPLETED ·Phase: PHASE4
-
An Efficacy Study of Paliperidone for the Prevention of Relapse in Participants With Schizophrenia
NCT01662310 ·Status: COMPLETED ·Phase: PHASE3
-
Quality of Life (QOL) in Female Patient With Schizophrenia
NCT00498004 ·Status: TERMINATED ·Phase: PHASE4
-
A Safety, Tolerability, and Treatment Response Study of Paliperidone Palmitate Administered to Patients With Schizophrenia
NCT01051531 ·Status: COMPLETED ·Phase: PHASE3
-
As Study of the Pharmacokinetics of Paliperidone Extended-release and Risperidone Immediate-release Formulations
NCT00796185 ·Status: COMPLETED ·Phase: PHASE1
-
Early Predictors of Poor Treatment Response in Patients With Schizophrenia Treated With Atypical Antipsychotics
NCT03730857 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Effectiveness and Safety of Paliperidone Extended-release (ER) Tablets in the Prevention of Recurrence in Adult Patients With Schizophrenia.
NCT00086320 ·Status: COMPLETED ·Phase: PHASE3
-
Extension Study To Evaluate The Long-Term Safety, Tolerability, And Efficacy Of Low And High Doses Of Bl-1020
NCT00722176 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess the Pharmacokinetics, Safety, and Tolerability of Paliperidone Palmitate in Patients With Schizophrenia
NCT01559272 ·Status: COMPLETED ·Phase: PHASE1
-
An Efficacy and Safety Study of Extended-Release (ER) Paliperidone in Adolescent Participants With Schizophrenia
NCT01009047 ·Status: COMPLETED ·Phase: PHASE3